Top Markets
Coin of the day
Xvivo Perfusion AB (publ) Xvivo Perfusion AB (publ)

Xvivo Perfusion AB (publ)

XVIVO
Peringkat dalam Saham #9727
Xvivo Perfusion AB (publ) is a medical technology company that creates and... Xvivo Perfusion AB (publ) is a medical technology company that creates and supplies advanced solutions for the preservation and perfusion of organs, tissues, and cells, primarily for use in transplantation. The company's global reach extends across Sweden, the United States, both North and South America, Europe, the Middle East, Africa, and the Asia Pacific region. Its product line includes the XVIVO System (XPS), an integrated, ready-to-use cardiac bypass system designed to facilitate safe normothermic ex vivo lung perfusion (EVLP). To support this, the XPS Disposable Lung Kit offers all the necessary sterile, pre-packed components for EVLP procedures. Xvivo also provides STEEN Solution, an optimally formulated buffered extracellular solution specifically for perfusing isolated donor lungs during EVLP. Additional offerings comprise Perfadex Plus, an extracellular, low-potassium, dextran-based electrolyte preservation solution, and the XVIVO Silicone Tubing Set, used for efficient flushing of donor lungs during the procurement process. The company also manufactures the XVIVO LS and XVIVO Disposable Lung Set, both critical devices for EVLP. Furthermore, Xvivo provides the XVIVO Organ Chamber, a sterile, single-use disposable container for temporarily housing isolated lungs before transplantation, and the XVIVO Lung Cannula Set, another sterile, single-use disposable medical product. Established in 1998, Xvivo Perfusion AB (publ) is headquartered in Gothenburg, Sweden.
Harga Saham
$30.43
Terakhir disinkronkan: 2026-08-28
Kapitalisasi Pasar
$958.38M
Perubahan (1 hari)
-3.95%
Perubahan (1 tahun)
71.66%
Negara
SE
Perdagangan Xvivo Perfusion AB (publ) (XVIVO)

Kategori

Harga XVIVO dengan kapitalisasi pasar B
Xvivo Perfusion AB (publ) Xvivo Perfusion AB (publ)
XVIVO
$30.43
Kapitalisasi pasar dari Xvivo Perfusion AB (publ)(XVIVO)
Kapitalisasi Pasar: $958.38M
Per August 2026, Xvivo Perfusion AB (publ) memiliki kapitalisasi pasar sebesar $958.38M. Ini menjadikan Xvivo Perfusion AB (publ) sebagai perusahaan 9727th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Xvivo Perfusion AB (publ) dari 2012 hingga 2026
XVIVO dibandingkan dengan 5 teratas stocks paling populer
Harga XVIVO Aset B Pasar B Hasil
Xvivo Perfusion AB (publ) Xvivo Perfusion AB (publ)
$167,110 $958.38M
$5.264T +549,145.58%
Xvivo Perfusion AB (publ) Xvivo Perfusion AB (publ)
$149,249 $958.38M
$4.701T +490,443.29%
Xvivo Perfusion AB (publ) Xvivo Perfusion AB (publ)
$132,611 $958.38M
$4.177T +435,757.53%
Xvivo Perfusion AB (publ) Xvivo Perfusion AB (publ)
$121,189 $958.38M
$3.817T +398,217.51%
Xvivo Perfusion AB (publ) Xvivo Perfusion AB (publ)
$90,996.35 $958.38M
$2.866T +298,981.00%